By Ed Coghlan.
The momentum for expanded use of medical marijuana continues in the U.S.
To date, 28 states and D.C. have legalized medical marijuana (MMJ). In 1996, only one state supported MMJ legalization. Attitudes have been changing fast in the country regarding the use of marijuana for medical reasons.
For chronic pain patients, medical marijuana has been an option many have used for years now. And with the impact of the government pressure on prescribing opioids for chronic pain meaning fewer prescriptions are being written, many patients are increasing their use of medical marijuana.
In Michigan, they are beginning to craft the state rules that will govern the industry. The state’s cities, townships and villages must decide whether they want in or out.
Michigan local officials are being bombarded with phone calls from people who want to gain a foothold in the medical marijuana business. Local cities have to balance whether allowing medical marijuana dispensaries and the revenue they generate are worth it politically. Many communities have seen resistance from people concerned about the marijuana industry.
The news is a little different in Connecticut where the state Board of Physicians recommended adding two debilitating conditions to Connecticut’s growing medical marijuana program, and also re-categorizing two others.
The board unanimously voted to add “intractable headache syndromes” and “neuropathic facial pain” to the list of new conditions pending approval by the legislature. It removed migraine headaches and Trigeminal neuralgia, which had been approved in June because they both have symptoms that fall under the broader term of “intractable headache syndromes.”
Currently, the program provides medical marijuana for adult patients with 22 debilitating conditions and for six different conditions for those 18 and younger.
Connecticut has more than 19,000 medical marijuana patients in the state and over 700 participating physicians.